Celestica's Q2 2026 earnings, released after the close on July 27, came at an important juncture for the electronics manufacturing services sector. As a key supplier of data center infrastructure, the company stands to benefit from ongoing AI-related capital spending. Shares had already declined about 36% from the 52-week high of $474.02 ahead of the report, so investors were particularly focused on whether demand momentum could hold. The CCS segment, driven by hyperscale cloud providers building out AI capacity, was the main area to watch. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. This quarter served as a useful test of Celestica's ability to scale revenue profitably while navigating supply chain issues.
The results came in well ahead of expectations across the board. Revenue reached $4.70 billion, a 62% increase from $2.89 billion in Q2 2025. That figure cleared both the consensus range of roughly $4.38 billion to $4.39 billion and the top end of the company's own guidance. On the bottom line, GAAP diluted EPS was $3.17 versus $1.82 a year earlier. Adjusted EPS of $2.54 exceeded analyst estimates of about $2.29 to $2.31 and management's range of $2.14 to $2.34. Net earnings totaled $368.8 million.
Margins also improved. GAAP operating margin rose to 9.8% from 9.4%, while adjusted operating margin reached a record 8.2%, up from 7.4%. The CCS segment remained the standout, with revenue climbing 84% to $3.81 billion and segment margin expanding to 8.7% from 8.3%. Hardware Platform Solutions revenue within CCS grew 58% to around $1.9 billion. The ATS segment grew a steadier 8% to $0.89 billion, with margin improving to 6.3% from 5.3%.
Investors responded positively. Shares finished the regular session at $321.06, up 5.2%, then rose another 7.2% in after-hours trading to around $344. The move reflected both the size of the beat and the upward revision to full-year guidance. Sentiment had been measured before the print, partly due to the prior pullback and concerns around component availability. Management pointed to stronger second-half forecasts and better component supply as reasons for the raised outlook. The after-hours reaction suggested many viewed the results as confirmation of Celestica's position in the AI buildout.
Guidance for the rest of the year points to continued momentum. For Q3, Celestica expects revenue of $5.25 billion to $5.55 billion and adjusted EPS of $2.88 to $3.08. Full-year revenue guidance moved to $20.5 billion from $19.0 billion, with adjusted EPS lifted to $11.30 from $10.15. Free cash flow guidance increased to $600 million from $500 million, and the adjusted operating margin target rose to 8.4%.
CEO Rob Mionis noted that revenue growth should accelerate beyond the 65% rate expected for 2026, supported by robust demand and new programs. Adjusted EPS is projected to grow even faster than revenue in 2027, helped by margin expansion. Key areas to monitor include customer concentration in the CCS business, supply chain conditions for custom silicon and memory, and free cash flow discipline amid higher capital spending. The combination of a strong backlog, improving margins, and higher growth expectations leaves Celestica well positioned in the current environment.
When evaluating stocks in the AI infrastructure space like this one, I find Tickeron’s AI Screener helpful for quickly applying filters on technical patterns, fundamentals, and industry trends. It allows me to compare opportunities across the sector more efficiently than manual reviews and has become a regular part of my process for spotting relative strength or emerging setups.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The 50-day moving average for CLS moved above the 200-day moving average on October 05, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on September 03, 2026. You may want to consider a long position or call options on CLS as a result. In 68 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for CLS just turned positive on September 04, 2026. Looking at past instances where CLS's MACD turned positive, the stock continued to rise in 44 of 49 cases over the following month. The odds of a continued upward trend are 90%.
CLS moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CLS crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +7.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLS advanced for three days, in 310 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 297 of 337 cases where CLS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
The 10-day RSI Indicator for CLS moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 58 similar instances where the indicator moved out of overbought territory. In 36 of the 58 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
CLS broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLS's P/B Ratio (18.149) is very high in comparison to the industry average of (5.615). P/E Ratio (37.026) is within average values for comparable stocks, (81.453). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (1.658). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.388) is also within normal values, averaging (4.796).
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of electronics manufacturing services
Industry ElectronicComponents